Literature DB >> 14530789

Histamine: A mediator of inflammation.

Donald MacGlashan1.   

Abstract

Histamine and its receptors, including the recently discovered receptors (H(3) and H(4)), novel sources of histamine, and the place of histamine in mediator networks continue to be areas of great interest. The 4 major subtypes of histamine receptors, H(1) to H(4), differ in their location, second messengers, and histamine-binding characteristics. In addition, it would appear that different histamine receptor agonists and antagonists bind to different portions of the receptor complex. A fifth receptor subtype, the intracellular H(IC), has only been defined by its location within cell types that are not traditionally associated with histamine. In airway tissue, most cells express at least 1 subtype of histamine receptor; however, blockade of these receptors does not completely abolish the inflammatory response. In addition, some H(1)-antihistamines might also exert anti-inflammatory effects by pathways independent of H(1)-receptor binding. Studies of selected second-generation H(1)-antihistamines have shown that these agents inhibit the release of certain cytokines from basophils, acting at a point downstream from the calcium signaling pathway. It has not yet been determined whether this action represents a class effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530789     DOI: 10.1016/s0091-6749(03)01877-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  32 in total

Review 1.  Histamine H4 antagonism: a therapy for chronic allergy?

Authors:  Bruce L Daugherty
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 2.  Mechanisms for amplified mediator release from colonic mast cells: implications for intestinal inflammatory diseases.

Authors:  Kim E Barrett
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

Review 3.  Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease.

Authors:  Monica G Lawrence; Judith A Woodfolk; Alexander J Schuyler; Leland C Stillman; Martin D Chapman; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2016-07-14       Impact factor: 10.793

4.  Modulation of tissue inflammatory response by histamine receptors in scorpion envenomation pathogenesis: involvement of H4 receptor.

Authors:  Amal Lamraoui; Sonia Adi-Bessalem; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

5.  Involvement of the H1 Histamine Receptor, p38 MAP Kinase, Myosin Light Chains Kinase, and Rho/ROCK in Histamine-Induced Endothelial Barrier Dysfunction.

Authors:  Shaquria P Adderley; Xun E Zhang; Jerome W Breslin
Journal:  Microcirculation       Date:  2015-05       Impact factor: 2.628

Review 6.  The role of basophils as innate immune regulatory cells in allergy and immunotherapy.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Andrea Sboarina; Antonio Vella
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

7.  Cutting edge: rapid accumulation of epidermal CCL27 in skin-draining lymph nodes following topical application of a contact sensitizer recruits CCR10-expressing T cells.

Authors:  Victor Huang; Anke S Lonsdorf; Lei Fang; Takashi Kakinuma; Vivian C Lee; Emily Cha; Hong Zhang; Keisuke Nagao; Marzanna Zaleska; Waldemar L Olszewski; Sam T Hwang
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 8.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

9.  Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine.

Authors:  Nelly Frossard; Margherita Strolin-Benedetti; Ashok Purohit; Gabrielle Pauli
Journal:  Br J Clin Pharmacol       Date:  2007-10-29       Impact factor: 4.335

10.  Histamine-induced vasodilatation in the human forearm vasculature.

Authors:  Euan A Sandilands; Jane Crowe; Hayley Cuthbert; Paul J Jenkins; Neil R Johnston; Michael Eddleston; D Nicholas Bateman; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.